Home
/
AIM ImmunoTech Inc.
/
Financials
/
Quarterly
AIM ImmunoTech Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that AIM ImmunoTech Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$26.0K
Nov 17, 2025
Q2
2025
Jun 30, 2025
$25.0K
Aug 14, 2025
Q1
2025
Mar 31, 2025
$16.0K
May 15, 2025
Q3
2025
Sep 30, 2024
$35.0K
Nov 17, 2025
Q2
2025
Jun 30, 2024
$50.0K
Aug 14, 2025
Q1
2025
Mar 31, 2024
$40.0K
May 15, 2025
Q3
2024
Sep 30, 2023
$46.0K
Nov 14, 2024
Q2
2024
Jun 30, 2023
$42.0K
Aug 14, 2024
Q1
2024
Mar 31, 2023
$49.0K
May 15, 2024
Q3
2023
Sep 30, 2022
$21.0K
Nov 14, 2023
Q2
2023
Jun 30, 2022
$30.0K
Aug 14, 2023
Q1
2023
Mar 31, 2022
$33.0K
May 15, 2023
Q3
2018
Sep 30, 2018
$38.0K
Nov 14, 2018
Q2
2018
Jun 30, 2018
$33.0K
Aug 14, 2018
Q3
2018
Sep 30, 2017
$90.0K
Nov 14, 2018
Q2
2018
Jun 30, 2017
$213.0K
Aug 14, 2018
Q3
2015
Sep 30, 2015
$23.0K
Nov 16, 2015
Q2
2015
Jun 30, 2015
$47.0K
Aug 12, 2015
Q1
2015
Mar 31, 2015
$36.0K
May 12, 2015
Q3
2015
Sep 30, 2014
$45.0K
Nov 16, 2015
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$26.0K
Nov 17, 2025
Q2
2025
Jun 30, 2025
$25.0K
Aug 14, 2025
Q1
2025
Mar 31, 2025
$16.0K
May 15, 2025
Q3
2025
Sep 30, 2024
$35.0K
Nov 17, 2025
Q2
2025
Jun 30, 2024
$50.0K
Aug 14, 2025
Q1
2025
Mar 31, 2024
$40.0K
May 15, 2025
Q3
2024
Sep 30, 2023
$46.0K
Nov 14, 2024
Q2
2024
Jun 30, 2023
$42.0K
Aug 14, 2024
Q1
2024
Mar 31, 2023
$49.0K
May 15, 2024
Q3
2023
Sep 30, 2022
$21.0K
Nov 14, 2023
Q2
2023
Jun 30, 2022
$30.0K
Aug 14, 2023
Q1
2023
Mar 31, 2022
$33.0K
May 15, 2023
Q3
2022
Sep 30, 2021
$33.0K
Nov 14, 2022
Q2
2022
Jun 30, 2021
$23.0K
Aug 15, 2022
Q1
2022
Mar 31, 2021
$28.0K
May 13, 2022
Q3
2021
Sep 30, 2020
$36.0K
Nov 15, 2021
Q2
2021
Jun 30, 2020
$40.0K
Aug 16, 2021
Q1
2021
Mar 31, 2020
$45.0K
May 17, 2021
Q3
2020
Sep 30, 2019
$61.0K
Nov 12, 2020
Q2
2020
Jun 30, 2019
$29.0K
Aug 14, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$56.0K
May 15, 2018
Q3
2017
Sep 30, 2017
$90.0K
Nov 14, 2017
Q2
2017
Jun 30, 2017
$213.0K
Aug 14, 2017
Q1
2018
Mar 31, 2017
$84.0K
May 15, 2018
Q3
2017
Sep 30, 2016
$22.0K
Nov 14, 2017
Q2
2017
Jun 30, 2016
$15.0K
Aug 14, 2017
Q1
2017
Mar 31, 2016
$39.0K
May 15, 2017
Q3
2016
Sep 30, 2015
$23.0K
Nov 14, 2016
Q2
2016
Jun 30, 2015
$47.0K
Aug 15, 2016
Q1
2016
Mar 31, 2015
$36.0K
May 16, 2016
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.28M)
Nov 17, 2025
Q3
2025
Jun 30, 2025
($2.79M)
Nov 17, 2025
Q2
2025
Jun 30, 2025
($2.79M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($3.71M)
May 15, 2025
Q2
2025
Mar 31, 2025
($3.71M)
Aug 14, 2025
Q3
2025
Mar 31, 2025
($3.71M)
Nov 17, 2025
Q3
2025
Sep 30, 2024
($3.70M)
Nov 17, 2025
Q3
2025
Jun 30, 2024
($1.84M)
Nov 17, 2025
Q2
2025
Jun 30, 2024
($1.84M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($5.82M)
Nov 17, 2025
Q2
2025
Mar 31, 2024
($5.82M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($5.82M)
May 15, 2025
Q3
2024
Sep 30, 2023
($7.82M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($4.91M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($3.66M)
May 15, 2024
Q3
2023
Sep 30, 2022
($6.39M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($4.85M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($3.82M)
May 15, 2023
Q3
2022
Sep 30, 2021
($3.83M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($5.88M)
Aug 15, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.45M)
Nov 17, 2025
Q2
2025
Jun 30, 2025
($2.65M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($3.62M)
May 15, 2025
Q3
2025
Sep 30, 2024
($4.49M)
Nov 17, 2025
Q2
2025
Jun 30, 2024
($3.69M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($5.73M)
May 15, 2025
Q3
2024
Sep 30, 2023
($8.16M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($5.46M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($4.30M)
May 15, 2024
Q3
2023
Sep 30, 2022
($6.52M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($4.70M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($3.15M)
May 15, 2023
Q3
2022
Sep 30, 2021
($3.93M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($3.72M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($3.75M)
May 13, 2022
Q3
2021
Sep 30, 2020
($3.36M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($3.34M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($3.33M)
May 17, 2021
Q3
2020
Sep 30, 2019
($3.21M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($3.22M)
Aug 14, 2020